Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endometrial cancer risk and survival by tumor MMR status.
Nagle CM, O'Mara TA, Tan Y, Buchanan DD, Obermair A, Blomfield P, Quinn MA, Webb PM, Spurdle AB; Australian Endometrial Cancer Study Group. Nagle CM, et al. Among authors: spurdle ab. J Gynecol Oncol. 2018 May;29(3):e39. doi: 10.3802/jgo.2018.29.e39. Epub 2018 Feb 23. J Gynecol Oncol. 2018. PMID: 29533022 Free PMC article.
CYP17 promotor polymorphism and ovarian cancer risk.
Spurdle AB, Chen X, Abbazadegan M, Martin N, Khoo SK, Hurst T, Ward B, Webb PM, Chenevix-Trench G. Spurdle AB, et al. Int J Cancer. 2000 May 1;86(3):436-9. doi: 10.1002/(sici)1097-0215(20000501)86:3<436::aid-ijc21>3.0.co;2-a. Int J Cancer. 2000. PMID: 10760835 Free article.
BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.
Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, McGurie V, DiCioccio RA, Duffy D, Chenevix-Trench G. Kelemen L, et al. Gynecol Oncol. 2005 Jun;97(3):807-12. doi: 10.1016/j.ygyno.2005.03.007. Gynecol Oncol. 2005. PMID: 15904951
461 results